VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $617,244 (100.0% shares, 0.0% debt)

Holdings (27)

ACRS Aclaris Therapeutics Inc 12.7%
Value ($000) $78,683 Shares 4,563,962 Est. Cost $13.57 Unrealized +0.5%
Instil Bio Inc 12.0%
Value ($000) $73,800 Shares 6,865,076 Est. Cost $25.08 Unrealized
RLMD Relmada Therapeutics Inc 9.9%
Value ($000) $61,269 Shares 2,270,072 Est. Cost $31.54 Unrealized -34.4%
TVTX Travere Therapeutics Inc 8.3%
Value ($000) $51,411 Shares 1,994,997 Est. Cost $19.66 Unrealized +35.0%
GHRS GH Research PLC 6.1%
Value ($000) $37,514 Shares 2,051,060 Est. Cost $20.66 Unrealized -14.5%
Tricida Inc 6.0%
Value ($000) $36,948 Shares 4,494,851 Est. Cost $8.83 Unrealized
VRDN Viridian Therapeutics Inc 5.6%
Value ($000) $34,260 Shares 1,852,919 Est. Cost $18.59 Unrealized +3.4%
Marinus Pharmaceuticals Inc 4.8%
Value ($000) $29,516 Shares 3,156,803 Est. Cost $11.98 Unrealized
CLDX Celldex Therapeutics Inc 4.8%
Value ($000) $29,466 Shares 865,116 Est. Cost $15.71 Unrealized +103.5%
WHWK Aadi Bioscience Inc 4.2%
Value ($000) $25,954 Shares 1,529,402 Est. Cost $30.48 Unrealized -37.1%
Chinook Therapeutics Inc 3.4%
Value ($000) $21,003 Shares 1,283,821 Est. Cost $16.31 Unrealized
LIANY LianBio 3.2%
Value ($000) $19,954 Shares 5,378,341 Est. Cost $6.16 Unrealized
VistaGen Therapeutics Inc 3.2%
Value ($000) $19,899 Shares 16,047,286 Est. Cost $2.02 Unrealized
Athira Pharma Inc 2.2%
Value ($000) $13,500 Shares 1,000,000 Est. Cost $20.05 Unrealized
Eiger BioPharmaceuticals Inc 2.0%
Value ($000) $12,199 Shares 1,469,767 Est. Cost $8.30 Unrealized
NUVL Nuvalent Inc 1.8%
Value ($000) $11,167 Shares 803,951 Est. Cost $29.01 Unrealized -49.9%
Graphite Bio Inc 1.3%
Value ($000) $8,224 Shares 1,612,617 Est. Cost $30.73 Unrealized
Provention Bio Inc 1.3%
Value ($000) $8,189 Shares 1,118,653 Est. Cost $7.32 Unrealized
COGT Cogent Biosciences Inc 1.3%
Value ($000) $8,155 Shares 1,088,817 Est. Cost $10.99 Unrealized -36.6%
ATYR aTyr Pharma Inc 1.2%
Value ($000) $7,484 Shares 1,398,889 Est. Cost $5.98 Unrealized -5.3%
Affimed NV 1.0%
Value ($000) $6,243 Shares 1,428,571 Est. Cost $5.52 Unrealized
Sierra Oncology Inc 0.8%
Value ($000) $5,207 Shares 162,479 Est. Cost $32.05 Unrealized
ALT Altimmune Inc 0.7%
Value ($000) $4,627 Shares 759,719 Est. Cost $7.36 Unrealized 0.0%
CNTA Centessa Pharmaceuticals PLC 0.6%
Value ($000) $3,690 Shares 411,361 Est. Cost $22.21 Unrealized
Astria Therapeutics Inc 0.6%
Value ($000) $3,617 Shares 538,999 Est. Cost $8.84 Unrealized
Aerovate Therapeutics Inc 0.4%
Value ($000) $2,769 Shares 151,037 Est. Cost $18.33 Unrealized
SVRA Savara Inc 0.4%
Value ($000) $2,496 Shares 1,905,265 Est. Cost $1.20 Unrealized 0.0%